Craft

Xiangxue Pharmaceutical

Revenue

¥1.8 B

FY, 2024

Xiangxue Pharmaceutical Summary

Company Summary

Overview
Xiangxue Pharmaceutical (also known as XPH) is a pharmaceutical company. It offers traditional Chinese medicines and herbals in the dosage forms of granules, liquids, and herbal teas. The company also provides medical devices such as disposable stereoscopic fixation systems for the brain, medical aural and encephalic adhesives, endoscopic trocar, etc.
Type
Public
Status
Active
Founded
1997
HQ
广州市, CN | view all locations
Website
http://xphcn.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • 广州市, 广东省 HQ

    China

    No. 28, 凝彩路 Central District

Xiangxue Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
¥324.7M
Gross profit (Q3, 2025)
¥121.2M
Net income (Q3, 2025)
(¥121.4M)
Cash (Q3, 2025)
¥125.8M
EBIT (Q3, 2025)
(¥50.6M)

Footer menu